Oklahoma City, OK – The Oklahoma Health Care Authority launched an initiative to cure SoonerCare members who have been diagnosed with the hepatitis C virus (HCV). Mavyret (glecaprevir/ pibrentasvir) is now the preferred direct-acting antiviral (DAA) medication for HCV and is available without prior authorization (PA) for Sooner-Care members. Removing the prior authorization allows for easier…